Modified amino acids

US10112900B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10112900-B2
Application numberUS-201715600632-A
CountryUS
Kind codeB2
Filing dateMay 19, 2017
Priority dateAug 31, 2012
Publication dateOct 30, 2018
Grant dateOct 30, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are modified amino acids comprising an azido group, polypeptides, antibodies and conjugates comprising the modified amino acids, and methods of producing the polypeptides, antibodies and conjugates comprising the modified amino acids. The polypeptides, antibodies and conjugates are useful in methods of treatment and prevention, methods of detection and methods of diagnosis.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound according to formula I: or a salt thereof, wherein: D is Ar—W 3 — or —W 1 —Y 1 —C(O)—Y 2 —W 2 —; Ar is each of W 1 , W 2 , and W 3 is independently a single bond or lower alkylene; X 1 is —O— or —S—; Y 1 is a single bond, —NH—, or —O—; Y 2 is an N-linked or C-linked divalent pyrrolidine radical; and one of Z 1 , Z 2 , and Z 3 is —N— and the others of Z 1 , Z 2 , and Z 3 are independently —CH—. 2. The compound of claim 1 , wherein D is —Ar—W 3 —. 3. The compound of claim 1 , wherein D is —W 1 —Y 1 —C(O)—Y 2 —W 2 —. 4. The compound of claim 1 , wherein: D is —Ar—W 3 —; and Ar is 5. The compound of claim 1 , wherein: D is —Ar—W 3 —; and Ar is 6. The compound of claim 1 , wherein: D is —Ar—W 3 —; W 3 is —CH 2 —; and Ar is 7. The compound of claim 1 wherein: D is —W 1 —Y 1 —C(O)—Y 2 —W 2 —; and Y 1 is —NH— or —O—. 8. The compound of claim 1 , wherein: D is —W 1 —Y 1 —C(O)—Y 2 —W 2 —; and W 2 is a single bond. 9. The compound of claim 1 according to formula Ia: 10. The compound of claim 1 , wherein each of W 2 and W 3 is independently C 1 -C 3 alkylene. 11. The compound of claim 1 according to any of formulas (1)-(5), (7)-(17), (24)-(29), and 40: or a salt thereof. 12. A compound according to formula II: or a salt thereof, wherein W 4 is C 1 -C 10 alkylene. 13. The compound of claim 12 according to formula 30: or a salt thereof.

Assignees

Inventors

Classifications

  • Immunomodulators · CPC title

  • Antineoplastic agents · CPC title

  • Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

  • Granulocyte CSF; Granulocyte-macrophage CSF · CPC title

  • to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10112900B2 cover?
Provided herein are modified amino acids comprising an azido group, polypeptides, antibodies and conjugates comprising the modified amino acids, and methods of producing the polypeptides, antibodies and conjugates comprising the modified amino acids. The polypeptides, antibodies and conjugates are useful in methods of treatment and prevention, methods of detection and methods of diagnosis.
Who is the assignee on this patent?
Sutro Biopharma Inc
What technology area does this patent fall under?
Primary CPC classification C07D213/55. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).